Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05311527 · ClinicalTrials.gov registry record · NA

UroLift System With SAbR for Prostate Cancer and BPH

A NA study of Prostate Cancer, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT05311527 is a NA study of Prostate Cancer that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 15 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05311527, a NA study of Prostate Cancer, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

Confirming safety of combining UroLift System prior to SAbR for patients with newly diagnosed prostate cancer and a history of BPH, by measuring the acute complication rate of UroLift System implant in patients with BPH undergoing SAbR (within 90 days of treatment completion)

Conditions Studied

Prostate Cancer

Interventions

  • RADIATION SABR
  • DEVICE Urolift

Study Locations (1)

Texas

  • University of Texas Southwestern Medical Center - Dallas - Dallas

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-01-11
Est. Completion 2025-10-29
Phase NA

Sponsor

University of Texas Southwestern Medical Center

837 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05311527

The ClinicalTrials.gov registry entry for NCT05311527 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (98% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which SABR is the first listed.

NCT05311527 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05311527 about?

NCT05311527 is a clinical study titled "UroLift System With SAbR for Prostate Cancer and BPH". Confirming safety of combining UroLift System prior to SAbR for patients with newly diagnosed prostate cancer and a history of BPH, by measuring the acute complication rate of UroLift System implant in patients with BPH undergoing SAbR (within 90 days of treatment completion)

What is the current status of trial NCT05311527?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-01-11. Estimated completion is 2025-10-29.

What conditions does trial NCT05311527 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05311527?

The interventions under investigation include: SABR (RADIATION), Urolift (DEVICE).

Who is sponsoring clinical trial NCT05311527?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05311527 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.